MedTrace Logo

Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures

NCT02734316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 531

Last updated 2018-02-08

No results posted yet for this study

Summary

The use of Direct Oral Anti-Coagulants (DOACs) is expanding, but their proper management in patients undergoing endoscopic procedures is still not completely clear. Current European guidelines are based on weak data. This observational study aims to evaluate the peri-endoscopic management of DOACs in clinical practice and the incidence of adverse events.

Conditions

  • Anticoagulant Disorders

Interventions

OTHER

endoscopic procedure

Evaluation of adverse events in patients on DOACs undergoing GI endoscopy

Sponsors & Collaborators

  • Valduce Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734316 on ClinicalTrials.gov